Login / Signup

Impacts of X-linked Retinitis Pigmentosa and Patient Pathways in European Countries: Results from the Cross-sectional EXPLORE XLRP-1 Physician Survey.

Katalin PungorJennifer LeeTom R DeneeYerkebulan KambarovRiikka NissinenKevin AmpehMarco PellegriniFrancesco Parmeggiani
Published in: Advances in therapy (2024)
The diagnosis, genetic testing, and management pathways among patients with XLRP can vary considerably. There is a need for more standardized diagnosis and management pathways, and QoL assessments, due to the major impact that XLRP has on patients' lives.
Keyphrases
  • cross sectional
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • primary care
  • emergency department
  • peritoneal dialysis
  • patient reported